SeraFluco contains Fluconazole 150 mg, a potent triazole antifungal agent that inhibits fungal cell membrane synthesis. It is highly effective against a wide range of fungal infections, particularly those caused by Candida and Cryptococcus species. With excellent oral bioavailability and once-weekly dosing, SeraFluco provides targeted, convenient, and reliable antifungal therapy. Indications; SeraFluco is indicated for the treatment and prevention of: Vaginal candidiasis (vaginal yeast infections) Oropharyngeal and esophageal candidiasis Systemic candidiasis Dermatophytosis (skin fungal infections like ringworm, athlete’s foot, etc.) Cryptococcal meningitis Fungal prophylaxis in immunocompromised patients (e.g., HIV/AIDS, chemotherapy) Key Benefits: Broad-Spectrum Antifungal: Effective against Candida, Cryptococcus, and dermatophytes. Rapid Symptom Relief: Quickly alleviates itching, burning, and discharge in vaginal and mucocutaneous infections. Convenient Dosing: Single-dose therapy for vaginal candidiasis enhances patient compliance. High Oral Bioavailability: Ensures effective systemic levels even with oral administration. Well-Tolerated: Minimal side effects with excellent safety profile for short and long-term use.
Panchkula
+919530953095
Chat with us
Chat with us